Supplementing with 4,000 IU of vitamin D decreased disease progression by 36% in people with colorectal cancer compared to placebo.
www.genengnews.com
Patients were given vitamin D or placebo in conjunction with standard chemotherapeutics used to treat colorectal cancer.
This study was too small to get any significant effect on overall survival so a larger scale trial is being planned to evaluate the effect of vitamin D on overall survival in colorectal cancer patients.
Enjoying this research? Get deeper insights like this delivered every other week.
Every other week our Premium Members receive deep dives like this alongside Rhonda's commentary and 8+ other hand-picked papers.
This gene and bioengineering press release does a good job explaining the research and interviewing the study authors. It is worth a quick read.